Diabetes  /  Future Economic Burden

Despite recent advances, diabetes continues to be a major health threat for at least 29 million Americans who have it and the 86 million Americans with prediabetes. The biggest concerns for individuals with the disease are its many complications and co-morbidities; which can cause vision loss, heart disease, stroke, and other debilitating medical conditions. With the aging of the population and the rise in risk factors like obesity, these problems are going to skyrocket, making medical innovation more critical than ever.

9 Matching Facts

Search matching Facts:
No results to display
    • In the next 25 years, the number of people with diabetes and the cost to treat them, will both at least double.  
    • In 2034, annual spending on diabetes will increase to $336 billion.  
    • Annual direct and indirect costs- including undiagnosed diabetes, prediabetes, and gestational diabetes- are expected to grow from $218 billion in 2007 to $336 billion by 2034.  
    • Annual health care spending attributable to prediabetes or diabetes could rise from $206 billion in 2011 to $512 billion by 2021, with a cumulative cost of approximately $3.5 trillion.  
    • Health care spending attributable to diabetes is expected to nearly triple by 2034, to $336 billion.  
    • Between 2009 and 2034, annual diabetes-related spending is expected to increase from $113 billion to $336 billion (2007 dollars).  
    • Projected impact of changing demographic characteristics on the national cost of diabetes: 2002 – 2020 (in 2002 billions of dollars)  
    • The cost of complications for type 2 diabetics over a 30-year period are estimated at $47,240 per patient.  
    • The annual cost of diabetes, in 2002 dollars, could rise to an estimated $156 billion by 2010, and $192 billion by 2020.